NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy

by van den Heuvel, Michel M, Verheij, Marcel, Boshuizen, Rogier, Belderbos, José, Dingemans, Anne-Marie C, De Ruysscher, Dirk, Laurent, Julien, Tighe, Robert, Haanen, John, Quaratino, Sonia
Published 2015

T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein

by Laurent, Julien, Touvrey, Cedric, Gillessen, Silke, Joffraud, Magali, Vicari, Manuela, Bertrand, Caroline, Ongarello, Stefano, Liedert, Bernd, Gallerani, Elisa, Beck, Joachim, Omlin, Aurelius, Sessa, Cristiana, Quaratino, Sonia, Stupp, Roger, Gnad-Vogt, Ulrike S, Speiser, Daniel E
Published 2013